You just read:

Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause

News provided by

Noven Pharmaceuticals, Inc.

Jun 28, 2013, 05:26 ET